An abnormal ratio between Na' and K' conductances seems to be the cause for the depolarization and paralysis of skeletal muscle in primary hypokalemic periodic paralysis. Recently we have shown that the "K+ channel opener" cromakalim hyperpolarizes mammalian skeletal muscle fibers. Now we have studied the effects of this drug on the twitch force of muscle biopsies from normal and diseased human skeletal muscle. Cromakalim had little effect on the twitch force of normal muscle whereas it strongly improved the contraction force of fibers from patients suffering from hypokalemic periodic paralysis. Recordings of intracellular Kf and CI-activities in human muscle and isolated rat soleus muscle support the view that cromakalim enhances the membrane K+ conductance (gK'). These data indicate that "K' channel openers" may have a beneficial effect in primary hypokalemic periodic paralysis. T h e r e is good evidence that a depolarization of the muscle fiber membrane causes the loss of contractility in primary hypokalemic periodic paralysis (for review see Refs. 5 and 15). The pathophysiological basis for this disease seems to be an abnormal ratio in the relative conductances of Na+ and K+.'3,'5 Investigations on excised external intercostal muscle fibers revealed an unusual high Na+ conductance and fiber depolarization in primary hypokalemic periodic paralysis. l4 Based on these findings one would expect that an increase in membrane Kt conductance (gK+)
T h e r e is good evidence that a depolarization of the muscle fiber membrane causes the loss of contractility in primary hypokalemic periodic paralysis (for review see Refs. 5 and 15) . The pathophysiological basis for this disease seems to be an abnormal ratio in the relative conductances of Na+ and K+.'3,' 5 Investigations on excised external intercostal muscle fibers revealed an unusual high Na+ conductance and fiber depolarization in primary hypokalemic periodic paralysis. l4 Based on these findings one would expect that an increase in membrane Kt conductance (gK+)
should induce a membrane repolarization and an increase in muscle force in the periodic paralysis.
Recently, we have found that drugs known to enhance gK+ in smooth and cardiac muscle (for review see Refs. 4 and 8) exert a similar action also on human skeletal
Here we report about the effects of the "K+ channel opener" cromakalim on the twitch force of normal and diseased isolated human skeletal muscle. The data show that cromakalim strongly improves the muscle strength of fibers from patients with primary hypokalemic periodic paralysis, whereas no effect on twitch force was found in control muscle. The experiments were supplemented with measurements of intracellular K+ and C1-activities in human and rat muscle fibers in order to gain more insight into the pathophysiology of the disease and the mechanisms underlying the effects of cromakalim on skeletal muscle.
MATERIALS AND METHODS
The experiments were performed on biopsies of human skeletal muscle.'03" Specimens of fiber segments (4-6 cm long) were dissected from biceps brachii, deltoid, vastus medialis or vastus lateralis muscles under local anesthesia. Such fiber segments were obtained from (1) patients who consented that a muscle biopsy be carried out for the in vitro diagnosis of susceptibility to malignant hyperthermia; (2) patients who required a muscle biopsy for clinical diagnosis; and (3) patients with a known neuromuscular disease who consented to have a muscle biopsy for experimental reasons only. All procedures were in accordance with the Helsinki convention and the Ethics Committee of the Technical University of Munich. Intracellular ion activities were also measured in fibers from isolated rat soleus muscle.
The preparations were transferred to a perspex chamber (volume 2 mL, flow rate 6.5 mW min) and superfused at 36°C with a solution of the following composition3 (in mmol/L): NaCl 107.7; CaCL, 1.53; KC1 3.48; MgSO, 0.69; NaHCO, 26.2; NaH,PO, 1.67; Na-glucuronate 9.64; glucose 5.5; sucrose 7.6 (bubbled with 95% 02/5% CO,; pH 7.4). Micro-electrodes were drawn on a Brown Flaming micropipette puller (Sutter Instruments, San Rafael, CA, USA). Single-barrelled electrodes had tip diameters below 0.2 pm (filling solution 3 mol/L KC1, resistance 40-60 MOhm). The methods for the construction and calibration of the double-barrelled ionsensitive micro-electrodes (tip size 1.0-1.5 pm) are described in detail elsewhere.' The following combinations of ionexchanger, backfilling solution, and reference solution were used: K+-sensitive micro-electrodes (Corning 477317, 200 mmol/L KCl, 1 moYL Mg2+ acetate); CI--sensitive micro-electrodes (WP Instruments IE-170, 200 mmol/L KCl, 0.5 mol/L K+ sulfate). For the measurement of contraction force, a muscle fiber bundle was suspended in the perspex chamber with one end fixed and the other end fastened to a strain gauge (Hottinger Baldwin, Darmstadt, FRG). Silver plates on both sides of the preparation were used for direct ("field") stimulation. Supramaximal single square voltage pulses (2 msec duration, 100 V stimulus strength) were applied every 10 sec.
Drugs were applied via the bathing solution. Glibenclamide was obtained from Hoechst (Frankfurt, FRG); cromakalim (BRL 34915) was a gift from Beecham Pharmaceuticals (Gronau, FRG). Stock solutions (100 mmol/L cromakalim, 10 mmol/L glibenclamide) were prepared in dimethyl sulfoxide (DMSO). DMSO did not mimic the effects of cromakalim or glibenclamide.
RESULTS

Effects of Cromakalim on lntracellular K+ Activity.
The hyperpolarizing effect of cromakalirn on human and also rat skeletal muscle was accompanied by a small decrease in the intracellular Kf activity (aKi). Fig. 1 gives typical examples of the measurements of aK, in human and rat skeletal muscle cells. The baseline level of aKi of this control human muscle fiber, which had a resting membrane potential (Em) of -70 mV, was 95 mmol/L (Fig.  1A) . Addition of cromakalim to the bathing solution resulted in a membrane hyperpolarization of 15 mV and a decrease in aKi from 95 to about 93 mmol/L. The voltage difference between the K+-sensitive and the reference electrode (EDiff) was 0.5 mV. This amplitude is only a little higher than the noise level of our K+-sensitive micro-electrodes. Therefore, cromakalim-induced changes in aKi were close to the detection limit of the method. muscle fiber from an isolated rat soleus muscle. In this case, cromakalim induced a membrane hyperpolarization of 10 mV; aKi decreased from 93 to about 91 mmol/L. In summary, application of cromakalim resulted in a small decrease in aKi of human and rat skeletal muscle fibers. A quantitative analysis of this effect is summarized in Table 1 .
Effects of Cromakalim on lntracellular CI-Activity.
Cromakalim induced a decrease in intracellular C1-activity (aCli) of human and rat skeletal muscle. Figure 2 illustrates an example of this effect.
A relatively blunt double-barrelled C1--sensitive micro-electrode (tip diameter 1.5 km) was used in this experiment (rat soleus muscle). Fiber impalements with such electrodes resulted in recordings of low membrane potentials and relatively high aC1,. The effect of cromakalim on these fibers was a strong hyperpolarization (-20 mV or more) accompanied by a decrease in acti. Table 1 summarizes the recordings of aCli in rat and human fibers before and during the application of cromakalim.
Hypokalemic Periodic Paralysis. Muscle specimens were obtained from 4 patients with hypokalemic periodic paralysis. Fiber segments of these muscles had membrane potentials less negative than control values in solutions with normal extracellular K+ concentration (3.5 mmol/L). The average membrane potential obtained with singlebarrelled electrodes in 16 fibers of 4 control muscles was -80.7 +-5.3 mV (mean +-SD); 17 fibers from 4 patients with hypokalemic periodic paralysis had an average Em of -71 k 6.2 mV. The lower membrane potentials of the affected fibers are, however, not due to a decreased K+ equilibrium potential (EK) since an aKi of 93.1 2 1.6 mmol/L (mean t-SD, n = 5 fibers in 2 muscles) was found. Cromakalim induced a strong hyperpolarization in muscle fibers from patients with hypokalemic periodic paralysis. This is illustrated in Fig. 3 Twitch Force. The twitch force of segments of human skeletal muscle was tested by direct stimulation of the muscle bundles (stimulus strength 100 V, duration 2 msec). These experiments revealed a differential effect of cromakalim. The drug preferentially increased the twitch force of fiber bundles from patients with hypokalemic periodic paralysis but not from controls. An example of such recordings is illustrated in Fig. 4 . The registration in part A shows the effect of cromakalim on the twitch force of a control muscle. There was a relatively high contraction force in the standard solution. Application of the drug into the bathing solution did not increase the twitch force. In contrast, fiber bundles from patients with hypokalemic periodic paralysis exerted little (sometimes no) twitch force in the normal bathing solution. However, cromakalim increased the contraction force of these muscles several times (Fig. 4B ). This effect was only slowly reversible. After a 10-minute application of cromakalim, it took 30 minutes or more before the contraction force returned to the original value. All the measurements of twitch force before and during the application of cromakalim are summarized in Fig. 5 . The preferential effect of cromakalim on the diseased muscle is clearly visible (note the logarithmic scale). Cromakalim had this effect in a bathing solution containing 3.5 mmol/L [Kf], as well as 1 mmol/L [K+I,. 
Effects of Glibenclamide.
We have shown that tolbutamide antagonizes the effect of cromakalim on human skeletal muscle. Now we have found that glibenclamide, another sulfonylurea compound, also blocks the effects of cromakalim. Fig. 6 illustrates this antagonism in a fiber from a patient suffering from hypokalemic periodic paralysis. The resting potential of this fiber in a bathing solution of 1 mmoYL [K' ], was -50 mV. Cromakalim induced a membrane hyperpolarization of more than 40 mV. However, this effect was completely suppressed after 1 pmol/L glibenclamide was added to the cromakalim-containing solution. A similar observation was made on another 6 fibers, on which the effects of glibenclamide were explored.
In four other experiments the effects of glibenclamide on the contraction force of normal and diseased human skeletal muscle biopsies were tested. We observed that glibenclamide itself had no effect on the twitch force. However, it completely suppressed or prevented the contraction force-facilitating effect of cromakalim on fiber bundles from patients with hypokalemic periodic paralysis (not illustrated). In fact, the measurements with K+-sensitive micro-electrodes in the present study revealed a diminution of aK,. This finding, therefore, supports the idea that cromakalim enhances gK+ also in skeletal muscle. Previously, this has been demonstrated by means of current-voltage relationships.I8 The change in aCli seen during the application of cromakalim can be explained by the high C1-conductance of the muscle fiber membrane. This conductance leads to a passive C1-efflux when the membrane hyperpolarizes. Effects of cromakalim on fluxes of sodium and calcium ions have not been investigated in the present study. However, it is unlikely that a decrease in the Na+ conductance underlies the membrane hyperpolarization seen in the presence of cromakalim. Such an effect should result in an increase rather than a decrease of aKi. Effects of cromakalim on the membrane Ca2+ conductance or Ca2+ transport mechanisms are possible and should be investigated in future experiments.
The experiments in which the effects of glibenclamide were explored give an indication regarding the type of K+ channel activated by cromakalim. Glibenclamide seems to be a s ecific it antagonizes the effect of cromakalim in cardiac antagonist of ATP-dependent K+ channels7. P and muscle&17 and also in human skeletal muscle (present study). It seems very likely, therefore, that cromakalim hyperpolarizes human muscle by the opening of otherwise "silent", ATP-dependent K+ channels. Other K+ channels in skeletal muscle, like the A-channel, delayed rectifier, and calcium-activated potassium channels are not antagonized by gliben~lamide.~ Therefore, we find it unlikely that the conductance of these channels is modulated by cromakalim although no direct experimental evidence exists.
Cromakalim improved the contraction force of muscle fibers from patients with primary hypokalemic periodic paralysis. Two mechanisms are probably involved in this effect. First, slow inactivation of Na+ channels is a possible mechanism for reduced excitability in muscle fibers with low membrane potentials, e.g. in primary hypokalemic periodic paralysis.I6 This process is especially important because it operates around the resting membrane potential. Consequently, the observed repolarization could restore simultaneously normal excitability and contraction force. The second mechanism by which the cromakalim-induced repolarization could improve twitch force is based on the voltage dependency of the transduction protein between excitation and contra~tion.~ Recently, this protein has been identified as the dihydropyridine receptor in the transverse tubule membrane. It functions both as the voltage sensor for excitation-contraction coupling and as the slow calcium channel." The protein is half inactivated at a potential around -40 mV and can be reactivated by membrane repolarization.' Taken these results together, it is likely that the membrane repolarization induced by cromakalim (a) improves spread of excitation along the cell membrane and (b) enhances indirectly the release of calcium from the sarcoplasmic reticulum.
The next question concerns the different effect of cromakalim on the contraction force of normal and diseased muscle. The most likely explanation for this finding is the difference in membrane potential. Diseased fibers are depolarized in spite of a normal K+ equilibrium potential. In such a situation, "K+ channel openers" exert a strong hyperpolarizing effect (and an increase in contraction force, see above). The resting potentials of normal fibers, on the other hand, are close to the K+ equilibrium potential and cromakalim has little effect. Furthermore, inactivation of Na+ channels and of the transduction protein does not operate in the voltage range of the normal K+ equilibrium potential. It is understandable, therefore, that cromakalim does not improve the contraction force of normal muscle fibers.
Two main conclusions can be drawn from the present study. First, the data support the vieW5,13,15 that a low membrane potential is the cause for paralysis in primary hypokalemic periodic paralysis. Secondly, drugs from the class of "Kf channel openers" may have clinical relevance in the treatment of primary hypokalemic periodic paralysis. Since these drugs activate K+ channels in a variety of tissues (e.g., vascular smooth muscles) the therapeutical use may be limited by their side effects. Nevertheless, the concentrations used in our in vitro study are very likely above the concentrations necessary to exert an effect in a well perfused muscle. There is no ideal diffusion in muscle biopsies and the drug concentration in the center of the muscle tissue is below the concentration in the bathing solution.
